Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Physiol Genomics ; 44(8): 455-69, 2012 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-22395315

RESUMO

Keratinocyte terminal differentiation is the process that ultimately forms the epidermal barrier that is essential for mammalian survival. This process is controlled, in part, by signal transduction and gene expression mechanisms, and the epidermal growth factor receptor (EGFR) is known to be an important regulator of multiple epidermal functions. Using microarray analysis of a confluent cell density-induced model of keratinocyte differentiation, we identified 2,676 genes that are regulated by epidermal growth factor (EGF), a ligand of the EGFR. We further discovered, and separately confirmed by functional assays, that EGFR activation abrogates all of the known essential processes of keratinocyte differentiation by 1) decreasing the expression of lipid matrix biosynthetic enzymes, 2) regulating numerous genes forming the cornified envelope, and 3) suppressing the expression of tight junction proteins. In organotypic cultures of skin, EGF acted to impair epidermal barrier integrity, as shown by increased transepidermal water loss. As defective epidermal differentiation and disruption of barrier function are primary features of many human skin diseases, we used bioinformatic analyses to identify genes that are known to be associated with skin diseases. Compared with non-EGF-regulated genes, EGF-regulated genes were significantly enriched for skin disease genes. These results provide a systems-level understanding of the actions of EGFR signaling to inhibit keratinocyte differentiation, providing new insight into the role of EGFR imbalance in skin pathogenesis.


Assuntos
Epiderme/metabolismo , Receptores ErbB/metabolismo , Diferenciação Celular , Células Cultivadas , Fator de Crescimento Epidérmico/metabolismo , Receptores ErbB/genética , Humanos , Queratinócitos/citologia , Queratinócitos/metabolismo , Ligantes , Transdução de Sinais , Pele/metabolismo
2.
Res Nurs Health ; 34(5): 408-18, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21812005

RESUMO

In this methods article, we describe collection and storage of clinically acquired blood and adipose samples for transcript analysis in an ongoing study exploring obesity in renal transplant recipients. Total ribonucleic acid (RNA) was isolated from whole blood using the LeukoLOCK™ Total RNA Isolation System (n = 4), and comparisons between fresh and frozen samples were made. Abdominal subcutaneous adipose samples (n = 4) were obtained during kidney transplantation, flash frozen, and stored at -80°C. Adipose RNA was extracted using either the STAT-60 method modified for lipids or Trizol plus RNeasy extraction. Affymetrix HG-U133 plus 2.0 arrays and Affymetrix Human Gene 1.0 ST arrays were used for both blood and adipose transcriptome analysis. Purity, quality, and quantity of RNA were high with comparable results using both array platforms.


Assuntos
Tecido Adiposo/metabolismo , Preservação de Sangue/métodos , Coleta de Amostras Sanguíneas/métodos , Perfilação da Expressão Gênica/métodos , RNA/isolamento & purificação , Congelamento , Humanos , Sensibilidade e Especificidade , Análise Serial de Tecidos/métodos
3.
Carcinogenesis ; 30(3): 480-6, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19126641

RESUMO

3H-1,2-dithiole-3-thione (D3T) and its analogues 4-methyl-5-pyrazinyl-3H-1,2-dithiole-3-thione (OLT) and 5-tert-butyl-3H-1,2-dithiole-3-thione (TBD) are chemopreventive agents that block or diminish early stages of carcinogenesis by inducing activities of detoxication enzymes. While OLT has been used in clinical trials, TBD has been shown to be more efficacious and possibly less toxic than OLT in animals. Here, we utilize a robust and high-resolution chemical genomics procedure to examine the pharmacological structure-activity relationships of these compounds in livers of male rats by microarray analyses. We identified 226 differentially expressed genes that were common to all treatments. Functional analysis identified the relation of these genes to glutathione metabolism and the nuclear factor, erythroid derived 2-related factor 2 pathway (Nrf2) that is known to regulate many of the protective actions of dithiolethiones. OLT and TBD were shown to have similar efficacies and both were weaker than D3T. In addition, we identified 40 genes whose responses were common to OLT and TBD, yet distinct from D3T. As inhibition of cytochrome P450 (CYP) has been associated with the effects of OLT on CYP expression, we determined the half maximal inhibitory concentration (IC(50)) values for inhibition of CYP1A2. The rank order of inhibitor potency was OLT >> TBD >> D3T, with IC(50) values estimated as 0.2, 12.8 and >100 microM, respectively. Functional analysis revealed that OLT and TBD, in addition to their effects on CYP, modulate liver lipid metabolism, especially fatty acids. Together, these findings provide new insight into the actions of clinically relevant and lead dithiolethione analogues.


Assuntos
Anticarcinógenos , Perfilação da Expressão Gênica , Compostos Heterocíclicos com 1 Anel , Tionas , Tiofenos , Animais , Masculino , Ratos , Anticarcinógenos/farmacologia , Citocromo P-450 CYP1A2/metabolismo , Genômica , Glutationa/metabolismo , Compostos Heterocíclicos com 1 Anel/farmacologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Família Multigênica , Análise de Sequência com Séries de Oligonucleotídeos , Pirazinas , Ratos Endogâmicos F344 , Relação Estrutura-Atividade , Tionas/farmacologia , Tiofenos/farmacologia , Fator 2 Relacionado a NF-E2/metabolismo
4.
Toxicol Sci ; 112(1): 257-72, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19692669

RESUMO

Toxicogenomics has great potential for enhancing our understanding of environmental chemical toxicity, hopefully leading to better informed human health risk assessments. This study employed toxicogenomic technology to reveal species differences in response to two prototypical aryl hydrocarbon receptor (AHR) agonists 2,3,7,8-tetrachlorodibenzo-p-dioxin and the polychlorinated biphenyl (PCB) congener PCB 126. Dose-responses of primary cultures of rat and human hepatocytes were determined using species-specific microarrays sharing over 4000 gene orthologs. Forty-seven human and 79 rat genes satisfied dose-response criteria for both chemicals and were subjected to further analysis including the calculation of the 50% effective concentration and the relative potency (REP) of PCB 126 for each gene. Only five responsive orthologous genes were shared between the two species; yet, the geometric mean of the REPs for all rat and human modeled responsive genes were 0.06 (95% confidence interval [CI]; 0.03-0.1) and 0.002 (95% CI; 0.001-0.005), respectively, suggesting broad species differences in the initial events that follow AHR activation but precede toxicity. This indicates that there are species differences in both the specific genes that responded and the agonist potency and REP for those genes. This observed insensitivity of human cells to PCB 126 is consistent with more traditional measurements of AHR activation (i.e., cytochrome P450 1A1 enzyme activity) and suggests that the species difference in PCB 126 sensitivity is likely due to certain aspects of AHR function. That a species divergence also exists in this expanded AHR-regulated gene repertoire is a novel finding and should help when extrapolating animal data to humans.


Assuntos
Hepatócitos/efeitos dos fármacos , Bifenilos Policlorados/toxicidade , RNA Mensageiro/genética , Receptores de Hidrocarboneto Arílico/agonistas , Animais , Células Cultivadas , Relação Dose-Resposta a Droga , Hepatócitos/metabolismo , Humanos , Análise de Sequência com Séries de Oligonucleotídeos , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA